{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T01:07:38Z","timestamp":1695172058962},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4329","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T22:01:40Z","timestamp":1431640900000},"page":"1219-1222","source":"Crossref","is-referenced-by-count":6,"title":["Drug-induced Liver Injury with HHV-6 Reactivation"],"prefix":"10.2169","volume":"54","author":[{"given":"Masashi","family":"Fujita","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Imaizumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Okai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumichi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Asano N, Yoshikawa T, Suga S, et al. Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 93: 104-108, 1994.","DOI":"10.1542\/peds.93.1.104"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mori Y, Yamanishi K. HHV-6A, 6B, and 7: pathogenesis, host response, and Clinical disease. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Arvin A, Campadelli-Fiume G, Macarski E, et al, Eds. Cambridge University Press, Cambridge, United Kingdom, 2007: 833-842.","DOI":"10.1017\/CBO9780511545313.047"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol 37 (Suppl 1): S39-S46, 2006.","DOI":"10.1016\/S1386-6532(06)70010-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Andr&eacute;oletti L, L&eacute;v&ecirc;que N, Boulagnon C, Brasselet C, Fornes P. Viral causes of human myocarditis. Arch Cardiovasc Dis 102: 559-568, 2009.","DOI":"10.1016\/j.acvd.2009.04.010"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tohyama M, Yahata Y, Yasukawa M, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134: 1113-1117, 1998.","DOI":"10.1001\/archderm.134.9.1113"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 134: 1108-1112, 1998.","DOI":"10.1001\/archderm.134.9.1108"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 5: 1-8, 2006.","DOI":"10.2332\/allergolint.55.1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Takikawa H, Onji M. A proposal of the diagnostic scale of drug-induced liver injury. Hepatol Res 32: 250-251, 2005.","DOI":"10.1016\/j.hepres.2005.05.007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Takikawa H, Murata Y, Horiike N, Fukui H, Onji M. Drug-induced liver injury in Japan: an analysis of 1676 cases between 1997 and 2006. Hepatol Res 39: 427-431, 2009.","DOI":"10.1111\/j.1872-034X.2008.00486.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shiohara T, Takahashi R, Kano Y. Drug-induced hypersensitivity syndrome and viral reactivation. In: Drug Hypersensitivity. Picher WY, Ed. Basel, Karger, 2007: 224-239.","DOI":"10.1159\/000104205"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Moling O, Tappeiner L, Piccin A, et al. Treatment of DIHS\/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir: a hypothesis. Med Sci Monit 18: CS57-CS62, 2012.","DOI":"10.12659\/MSM.883198"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Aota N, Shiohara T. Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes. Autoimmun Rev 8: 488-494, 2009.","DOI":"10.1016\/j.autrev.2009.02.029"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Eshki M, Allanore L, Musette P, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol 145: 67-72, 2009.","DOI":"10.1001\/archderm.145.1.67"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tohyama M, Hashimoto K, Yasukawa M, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 157: 934-940, 2007.","DOI":"10.1111\/j.1365-2133.2007.08167.x"},{"key":"15","unstructured":"15. Toki K, Yokokawa K, Kameoka H, et al. A case of suspected of human herpesvirus-6 infection in renal transplantation. Ishoku (Japanese Journal of Transplantation) 31: 401-405, 1996 (in Japanese)."},{"key":"16","unstructured":"16. Nakamura K, Teraki Y, Isaki S. A case of drug-induced hypersensitivity syndrome with much pleural effusion by salazosulphapyridine. Hifuka no Rinsyo (Rinsho Derma) 53: 1143-1145, 2011 (in Japanese)."},{"key":"17","unstructured":"17. Nobuko Y, Tatsuno I, Kaneko K, et al. A case of diabetes with anticonvulsant hypersensitivity syndrome, hyponatoremia and human herpesvirus-6 reactivation. Nihon Naibunpi Gakkai Zasshi (Folia Endocrinologica Japonica) 78 (Suppl 3): 58-60, 2002 (in Japanese)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bonaci-Nikolic B, Jeremic I, Nikolic M, Andrejevic S, Lavadinovic L. High procalcitonin in a patient with drug hypersensitivity syndrome. Intern Med 48: 1471-1474, 2009.","DOI":"10.2169\/internalmedicine.48.2151"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wang F, Chi J, Peng G, et al. Development of virus-specific CD4<sup>+<\/sup> and CD8<sup>+<\/sup> regulatory T cells induced by human herpesvirus 6 infection. J Virol 88: 1011-1024, 2014.","DOI":"10.1128\/JVI.02586-13"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Flamand L, Gosselin J, D'Addario M, et al. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 65: 5105-5110, 1991.","DOI":"10.1128\/JVI.65.9.5105-5110.1991"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yoshikawa T, Kato Y, Ihira M, et al. Kinetics of cytokine and chemokine responses in patients with primary human herpesvirus 6 infection. J Clin Virol 50: 65-68, 2011.","DOI":"10.1016\/j.jcv.2010.09.017"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nastke MD, Becerra A, Yin L, et al. Human CD4<sup>+<\/sup> T cell response to human herpesvirus 6. J Virol 86: 4776-4792, 2012.","DOI":"10.1128\/JVI.06573-11"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology 39: 383-390, 2007.","DOI":"10.1080\/00313020701444564"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kano Y, Inaoka M, Sakuma K, Shiohara T. Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology 209: 165-167, 2005.","DOI":"10.1016\/j.tox.2004.12.013"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T04:39:12Z","timestamp":1651984752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/10\/54_54.4329\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4329","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}